Pages that link to "Q73167785"

The following pages link to Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures (Q73167785):

Displaying 11 items.

• Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition (Q24793013) (← links)
• The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte. (Q33796140) (← links)
• Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function (Q33845105) (← links)
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases (Q35209995) (← links)
• Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1. (Q35915798) (← links)
• Therapies for rheumatoid arthritis: hope springs eternal (Q36352913) (← links)
• Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes. (Q36465483) (← links)
• Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells (Q38904485) (← links)
• Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes (Q42585251) (← links)
• Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis (Q44623692) (← links)
• c-Jun N-terminal kinase (JNK) and p38 play different roles in age-related Purkinje cell death in murine organotypic culture. (Q51892507) (← links)